# Altria sues FDA over nicotine product delays

> The Marlboro maker says FDA red tape is blocking its nicotine pouches while illegal imports flood the market.
- Title: Altria sues FDA over nicotine product delays · Fortune
- Summary: The Marlboro maker says FDA red tape is blocking its nicotine pouches while illegal imports flood the market.
- Keywords: altria, sal mancuso, fda, nicotine pouches, on! brand, regulatory lawsuit, tobacco alternatives, Fortune
- URL: https://shortify.news/Fortune/altria-sues-fda-over-nicotine-product-delays
- Source: Fortune — https://fortune.com/2026/11/17/altria-ceo-says-responsibility-needs-to-be-at-the-heart-business-sued-fda
- Author: Sasha Rogelberg
- Read time: 1 min
- Topics: altria, sal mancuso, fda, nicotine pouches, on! brand, regulatory lawsuit, tobacco alternatives
## Altria pivots to nicotine alternatives
Altria Group, which owns Marlboro and Black and Mild, announced its Moving Beyond Smoking initiative in two thousand twenty-three as consumers shift away from cigarettes toward smoke-free alternatives.
## On! pouches face regulatory headwinds
CEO Sal Mancuso told Fortune at the Fortune five hundred Innovation Forum in Detroit on Monday that Altria's On! nicotine pouch brand is key to the company, but FDA regulations have slowed its growth.
## Mancuso on responsibility and regulation
Mancuso said Altria is the underdog in the pouch category but intends to lead it long term.

> responsibility needs to be at the heart of everything you do
## Altria sues FDA over review delays
Altria, through subsidiaries Helix Innovations and NJOY, sued the FDA in September, claiming the agency blocked newer nicotine products from reaching market through its Premarket Tobacco Product Application review process.
## Six months becomes six years
Mancuso said what should take the FDA six months to review was taking six years in some cases, allowing illegal products from China to take market share while skirting safety standards.
## Litigation paused, FDA considers changes
U.S. District Judge James Wesley Hendrix of the Northern District of Texas granted a joint request from the FDA and plaintiffs to pause litigation. The FDA said it would consider revisions to the review process.
## Key takeaway

Altria CEO Sal Mancuso says FDA regulations are slowing the company's nicotine pouch growth and giving illegal competitors an advantage.

---

Summary: Shortify — https://shortify.news/Fortune/altria-sues-fda-over-nicotine-product-delays
Reporting: Fortune — https://fortune.com/2026/11/17/altria-ceo-says-responsibility-needs-to-be-at-the-heart-business-sued-fda

When you use this summary, link the Shortify URL for the summary and credit the reporting to its newsroom.